Stephen D. Hall - Publications

Affiliations: 
Plymouth University, Plymouth, England, United Kingdom 

23/117 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Prokic EJ, Stanford IM, Woodhall GL, Williams AC, Hall SD. Bradykinesia Is Driven by Cumulative Beta Power During Continuous Movement and Alleviated by Gabaergic Modulation in Parkinson's Disease. Frontiers in Neurology. 10: 1298. PMID 31920922 DOI: 10.3389/fneur.2019.01298  1
2015 Prokic EJ, Weston C, Yamawaki N, Hall SD, Jones RS, Stanford IM, Ladds G, Woodhall GL. Cortical oscillatory dynamics and benzodiazepine-site modulation of tonic inhibition in fast spiking interneurons. Neuropharmacology. 95: 192-205. PMID 25797493 DOI: 10.1016/j.neuropharm.2015.03.006  1
2014 Lacey MG, Gooding-Williams G, Prokic EJ, Yamawaki N, Hall SD, Stanford IM, Woodhall GL. Spike firing and IPSPs in layer V pyramidal neurons during beta oscillations in rat primary motor cortex (M1) in vitro. Plos One. 9: e85109. PMID 24465488 DOI: 10.1371/journal.pone.0085109  1
2013 Rossiter HE, Worthen SF, Witton C, Hall SD, Furlong PL. Gamma oscillatory amplitude encodes stimulus intensity in primary somatosensory cortex. Frontiers in Human Neuroscience. 7: 362. PMID 23874282 DOI: 10.3389/fnhum.2013.00362  1
2013 McAllister CJ, Rönnqvist KC, Stanford IM, Woodhall GL, Furlong PL, Hall SD. Oscillatory beta activity mediates neuroplastic effects of motor cortex stimulation in humans. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 7919-27. PMID 23637183 DOI: 10.1523/JNEUROSCI.5624-12.2013  1
2013 Ronnqvist KC, McAllister CJ, Woodhall GL, Stanford IM, Hall SD. A multimodal perspective on the composition of cortical oscillations. Frontiers in Human Neuroscience. 7: 132. PMID 23596405 DOI: 10.3389/fnhum.2013.00132  1
2011 Pirttimaki TM, Hall SD, Parri HR. Sustained neuronal activity generated by glial plasticity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 7637-47. PMID 21613477 DOI: 10.1523/JNEUROSCI.5783-10.2011  1
2011 Worthen SF, Hobson AR, Hall SD, Aziz Q, Furlong PL. Primary and secondary somatosensory cortex responses to anticipation and pain: a magnetoencephalography study. The European Journal of Neuroscience. 33: 946-59. PMID 21323764 DOI: 10.1111/j.1460-9568.2010.07575.x  1
2011 Hall SD, Stanford IM, Yamawaki N, McAllister CJ, Rönnqvist KC, Woodhall GL, Furlong PL. The role of GABAergic modulation in motor function related neuronal network activity. Neuroimage. 56: 1506-10. PMID 21320607 DOI: 10.1016/j.neuroimage.2011.02.025  1
2010 Hall SD, Yamawaki N, Fisher AE, Clauss RP, Woodhall GL, Stanford IM. GABA(A) alpha-1 subunit mediated desynchronization of elevated low frequency oscillations alleviates specific dysfunction in stroke--a case report. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 121: 549-55. PMID 20097125 DOI: 10.1016/j.clinph.2009.11.084  1
2010 Hall SD, Barnes GR, Furlong PL, Seri S, Hillebrand A. Neuronal network pharmacodynamics of GABAergic modulation in the human cortex determined using pharmaco-magnetoencephalography. Human Brain Mapping. 31: 581-94. PMID 19937723 DOI: 10.1002/hbm.20889  1
2009 Hui DS, Chow BK, Ng SS, Chu LC, Hall SD, Gin T, Sung JJ, Chan MT. Exhaled air dispersion distances during noninvasive ventilation via different Respironics face masks. Chest. 136: 998-1005. PMID 19411297 DOI: 10.1378/chest.09-0434  1
2009 Hui DS, Chow BK, Chu LC, Ng SS, Hall SD, Gin T, Chan MT. Exhaled air and aerosolized droplet dispersion during application of a jet nebulizer. Chest. 135: 648-54. PMID 19265085 DOI: 10.1378/chest.08-1998  1
2008 Yamawaki N, Stanford IM, Hall SD, Woodhall GL. Pharmacologically induced and stimulus evoked rhythmic neuronal oscillatory activity in the primary motor cortex in vitro. Neuroscience. 151: 386-95. PMID 18063484 DOI: 10.1016/j.neuroscience.2007.10.021  1
2007 Ip M, Tang JW, Hui DS, Wong AL, Chan MT, Joynt GM, So AT, Hall SD, Chan PK, Sung JJ. Airflow and droplet spreading around oxygen masks: a simulation model for infection control research. American Journal of Infection Control. 35: 684-9. PMID 18063134 DOI: 10.1016/j.ajic.2007.05.007  1
2007 Hui DS, Hall SD, Chan MT, Chow BK, Ng SS, Gin T, Sung JJ. Exhaled air dispersion during oxygen delivery via a simple oxygen mask. Chest. 132: 540-6. PMID 17573505 DOI: 10.1378/chest.07-0636  1
2006 Hui DS, Ip M, Tang JW, Wong AL, Chan MT, Hall SD, Chan PK, Sung JJ. Airflows around oxygen masks: A potential source of infection? Chest. 130: 822-6. PMID 16963681 DOI: 10.1378/chest.130.3.822  1
2006 Hui DS, Hall SD, Chan MT, Chow BK, Tsou JY, Joynt GM, Sullivan CE, Sung JJ. Noninvasive positive-pressure ventilation: An experimental model to assess air and particle dispersion. Chest. 130: 730-40. PMID 16963670 DOI: 10.1378/chest.130.3.730  1
2005 Hall SD, Holliday IE, Hillebrand A, Furlong PL, Singh KD, Barnes GR. Distinct contrast response functions in striate and extra-striate regions of visual cortex revealed with magnetoencephalography (MEG). Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 116: 1716-22. PMID 15953561 DOI: 10.1016/j.clinph.2005.02.027  1
2005 Brookes MJ, Gibson AM, Hall SD, Furlong PL, Barnes GR, Hillebrand A, Singh KD, Holliday IE, Francis ST, Morris PG. GLM-beamformer method demonstrates stationary field, alpha ERD and gamma ERS co-localisation with fMRI BOLD response in visual cortex. Neuroimage. 26: 302-8. PMID 15862231 DOI: 10.1016/j.neuroimage.2005.01.050  1
2005 Hall SD, Holliday IE, Hillebrand A, Singh KD, Furlong PL, Hadjipapas A, Barnes GR. The missing link: analogous human and primate cortical gamma oscillations. Neuroimage. 26: 13-7. PMID 15862200 DOI: 10.1016/j.neuroimage.2005.01.009  1
2004 Brookes MJ, Gibson AM, Hall SD, Furlong PL, Barnes GR, Hillebrand A, Singh KD, Holliday IE, Francis ST, Morris PG. A general linear model for MEG beamformer imaging. Neuroimage. 23: 936-46. PMID 15528094 DOI: 10.1016/j.neuroimage.2004.06.031  1
2004 Hall SD, Barnes GR, Hillebrand A, Furlong PL, Singh KD, Holliday IE. Spatio-temporal imaging of cortical desynchronization in migraine visual aura: a magnetoencephalography case study. Headache. 44: 204-8. PMID 15012656 DOI: 10.1111/j.1526-4610.2004.04048.x  1
Low-probability matches
2020 Turner PK, Hall SD, Chapman SC, Rehmel J, Royalty J, Guo Y, Kulanthaivel P. Abemaciclib Does Not Have a Clinically Meaningful Effect on Pharmacokinetics of CYP1A2, CYP2C9, CYP2D6, and CYP3A4 Substrates in Patients with Cancer. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 32581049 DOI: 10.1124/dmd.119.090092  0.01
2020 Posada MM, Morse BL, Turner PK, Kulanthaivel P, Hall SD, Dickinson GL. Predicting Clinical Effects of CYP3A4 Modulators on Abemaciclib and Active Metabolites Exposure Using Physiologically Based Pharmacokinetic Modeling. Journal of Clinical Pharmacology. PMID 32080863 DOI: 10.1002/jcph.1584  0.01
2019 Gaetz W, Rhodes E, Bloy L, Blaskey L, Jackel CR, Brodkin ES, Waldman A, Embick D, Hall S, Roberts TP. Evaluating motor cortical oscillations and age-related change in autism spectrum disorder. Neuroimage. 116349. PMID 31726253 DOI: 10.1016/j.neuroimage.2019.116349  0.01
2019 Tres F, Posada MM, Hall SD, Mohutsky MA, Taylor LS. The Effect of Promiscuous Aggregation on in Vitro Drug Metabolism Assays. Pharmaceutical Research. 36: 170. PMID 31654151 DOI: 10.1007/s11095-019-2713-5  0.01
2019 Guo Y, Lucksiri A, Dickinson GL, Vuppalanchi RK, Hilligoss JK, Hall SD. Quantitative Prediction of CYP3A4 and CYP3A5-Mediated Drug Interactions. Clinical Pharmacology and Therapeutics. PMID 31356678 DOI: 10.1002/cpt.1596  0.01
2019 Morse BL, Alberts JJ, Posada MM, Rehmel J, Kolur A, Tham LS, Loghin C, Hillgren KM, Hall SD, Dickinson GL. Physiologically-Based Pharmacokinetic Modeling of Atorvastatin Incorporating Delayed Gastric Emptying and Acid-to-Lactone Conversion. Cpt: Pharmacometrics & Systems Pharmacology. PMID 31250974 DOI: 10.1002/psp4.12447  0.01
2019 Chen Y, Cabalu TD, Callegari E, Einolf H, Liu L, Parrott N, Peters SA, Schuck E, Sharma P, Tracey H, Upreti VV, Zheng M, Zhu AZX, Hall SD. Recommendations for the Design of Clinical Drug-Drug Interaction Studies with Itraconazole using a Mechanistic PBPK Model. Cpt: Pharmacometrics & Systems Pharmacology. PMID 31215774 DOI: 10.1002/psp4.12449  0.01
2018 Matsunaga N, Ufuk A, Morse BL, Bedwell DW, Bao J, Mohutsky MA, Hillgren KM, Hall SD, Houston JB, Galetin A. Hepatic OATP-mediated clearance in the Beagle dog: assessing in vitro-in vivo relationships and applying cross species empirical scaling factors to improve prediction of human clearance. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 30593544 DOI: 10.1124/dmd.118.084194  0.01
2018 Chappell JC, Kellie Turner P, Anne Pak Y, Bacon J, Chiang AY, Royalty J, Hall SD, Kulanthaivel P, Bonventre JV. Abemaciclib inhibits renal tubular secretion without changing glomerular filtration rate. Clinical Pharmacology and Therapeutics. PMID 30449032 DOI: 10.1002/cpt.1296  0.01
2018 Coutant DE, Hall SD. Drug Interaction Involving Direct or Indirect Cytokine Modulation Should Be Investigated in Select Circumstances. Journal of Clinical Pharmacology. PMID 30129667 DOI: 10.1002/jcph.1303  0.01
2018 Tres F, Posada MM, Hall SD, Mohutsky MA, Taylor LS. Mechanistic Understanding of the Phase Behavior of Supersaturated Solutions of Poorly Water-Soluble Drugs. International Journal of Pharmaceutics. PMID 29572154 DOI: 10.1016/j.ijpharm.2018.03.038  0.01
2018 Coutant DE, Hall SD. Disease-Drug Interactions in Inflammatory States via Effects on CYP-Mediated Drug Clearance. Journal of Clinical Pharmacology. PMID 29505093 DOI: 10.1002/jcph.1093  0.01
2018 Rhodes E, Gaetz WC, Marsden J, Hall SD. Transient Alpha and Beta Synchrony Underlies Preparatory Recruitment of Directional Motor Networks. Journal of Cognitive Neuroscience. 1-9. PMID 29488848 DOI: 10.1162/jocn_a_01250  0.01
2017 Amsden JJ, Herr PJ, Landry DMW, Kim W, Vyas R, Parker CB, Kirley MP, Keil AD, Gilchrist KH, Radauscher EJ, Hall SD, Carlson JB, Baldasaro N, Stokes D, Di Dona ST, et al. Proof of Concept Coded Aperture Miniature Mass Spectrometer Using a Cycloidal Sector Mass Analyzer, a Carbon Nanotube (CNT) Field Emission Electron Ionization Source, and an Array Detector. Journal of the American Society For Mass Spectrometry. PMID 29052038 DOI: 10.1007/s13361-017-1820-y  0.01
2017 Tres F, Hall SD, Mohutsky MA, Taylor LS. Monitoring the Phase Behavior of Supersaturated Solutions of Poorly Water-Soluble Drugs Using Fluorescence Techniques. Journal of Pharmaceutical Sciences. PMID 29031978 DOI: 10.1016/j.xphs.2017.10.002  0.01
2017 Posada MM, Cannady EA, Payne CD, Zhang X, Bacon JA, Pak YA, Higgins JW, Shahri N, Hall SD, Hillgren KM. Prediction of Transporter-Mediated Drug-Drug Interactions for Baricitinib. Clinical and Translational Science. PMID 28749581 DOI: 10.1111/cts.12486  0.01
2017 Rougee LRA, Mohutsky MA, Bedwell DW, Ruterbories KJ, Hall SD. The Impact of the Hepatocyte-to-Plasma pH Gradient on the Prediction of Hepatic Clearance and Drug-Drug Interactions for CYP2C9 and CYP3A4 Substrates. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 28679672 DOI: 10.1124/dmd.117.076331  0.01
2017 Tyagi V, Hanoch Y, Hall SD, Runco M, Denham SL. The Risky Side of Creativity: Domain Specific Risk Taking in Creative Individuals. Frontiers in Psychology. 8: 145. PMID 28217103 DOI: 10.3389/fpsyg.2017.00145  0.01
2016 Rougee LR, Mohutsky MA, Bedwell DW, Ruterbories KJ, Hall SD. The Impact of the Hepatocyte-to-Plasma pH Gradient on the Prediction of Hepatic Clearance and Drug-Drug Interactions for CYP2D6 Substrates. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 27590024 DOI: 10.1124/dmd.116.071761  0.01
2015 Steere B, Baker JA, Hall SD, Guo Y. Prediction of in vivo clearance and associated variability of CYP2C19 substrates by genotypes in populations utilizing a pharmacogenetics-based mechanistic model. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 43: 870-83. PMID 25845826 DOI: 10.1124/dmd.114.061523  0.01
2015 Small DS, Ke AB, Hall SD, Mantlo N, Rotelli M, Friedrich S. Assessment of the persistence of anacetrapib and evacetrapib concentrations using two pharmacokinetic modeling approaches. Journal of Clinical Pharmacology. 55: 757-67. PMID 25651523 DOI: 10.1002/jcph.472  0.01
2015 Posada MM, Bacon JA, Schneck KB, Tirona RG, Kim RB, Higgins JW, Pak YA, Hall SD, Hillgren KM. Prediction of renal transporter mediated drug-drug interactions for pemetrexed using physiologically based pharmacokinetic modeling. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 43: 325-34. PMID 25504564 DOI: 10.1124/dmd.114.059618  0.01
2015 Annes WF, Long A, Witcher JW, Ayan-Oshodi MA, Knadler MP, Zhang W, Mitchell MI, Cornelissen K, Hall SD. Relative contributions of presystemic and systemic peptidases to oral exposure of a novel metabotropic glutamate 2/3 receptor agonist (LY404039) after oral administration of prodrug pomaglumetad methionil (LY2140023). Journal of Pharmaceutical Sciences. 104: 207-14. PMID 25382826 DOI: 10.1002/jps.24226  0.01
2014 Dausch DE, Gilchrist KH, Carlson JB, Hall SD, Castellucci JB, von Ramm OT. In vivo real-time 3-D intracardiac echo using PMUT arrays. Ieee Transactions On Ultrasonics, Ferroelectrics, and Frequency Control. 61: 1754-64. PMID 25265183 DOI: 10.1109/TUFFC.2014.006452  0.01
2014 Mohutsky M, Hall SD. Irreversible enzyme inhibition kinetics and drug-drug interactions. Methods in Molecular Biology (Clifton, N.J.). 1113: 57-91. PMID 24523109 DOI: 10.1007/978-1-62703-758-7_5  0.01
2013 Quinney SK, Knopp S, Chang C, Hall SD, Li L. Integration of in vitro binding mechanism into the semiphysiologically based pharmacokinetic interaction model between ketoconazole and midazolam. Cpt: Pharmacometrics & Systems Pharmacology. 2: e75. PMID 24448021 DOI: 10.1038/psp.2013.50  0.01
2013 Xu C, Quinney SK, Guo Y, Hall SD, Li L, Desta Z. CYP2B6 pharmacogenetics-based in vitro-in vivo extrapolation of efavirenz clearance by physiologically based pharmacokinetic modeling. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 41: 2004-11. PMID 23846872 DOI: 10.1124/dmd.113.051755  0.01
2013 Topletz AR, Dennison JB, Barbuch RJ, Hadden CE, Hall SD, Renbarger JL. The relative contributions of CYP3A4 and CYP3A5 to the metabolism of vinorelbine. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 41: 1651-61. PMID 23780963 DOI: 10.1124/dmd.113.051094  0.01
2013 Dausch DE, Castellucci JB, Gilchrist KH, Carlson JB, Hall SD, von Ramm OT. Live volumetric imaging (LVI) intracardiac ultrasound catheter. Cardiovascular Revascularization Medicine : Including Molecular Interventions. 14: 157-9. PMID 23773496 DOI: 10.1016/j.carrev.2013.03.008  0.01
2013 Han B, Mao J, Chien JY, Hall SD. Optimization of drug-drug interaction study design: comparison of minimal physiologically based pharmacokinetic models on prediction of CYP3A inhibition by ketoconazole. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 41: 1329-38. PMID 23584886 DOI: 10.1124/dmd.112.050732  0.01
2013 Gombar VK, Hall SD. Quantitative structure-activity relationship models of clinical pharmacokinetics: clearance and volume of distribution. Journal of Chemical Information and Modeling. 53: 948-57. PMID 23451981 DOI: 10.1021/ci400001u  0.01
2013 Baker JA, Wickremsinhe ER, Li CH, Oluyedun OA, Dantzig AH, Hall SD, Qian YW, Ring BJ, Wrighton SA, Guo Y. Pharmacogenomics of gemcitabine metabolism: functional analysis of genetic variants in cytidine deaminase and deoxycytidine kinase. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 41: 541-5. PMID 23230131 DOI: 10.1124/dmd.112.048769  0.01
2013 Tandra S, Chalasani N, Jones DR, Mattar S, Hall SD, Vuppalanchi R. Pharmacokinetic and pharmacodynamic alterations in the Roux-en-Y gastric bypass recipients. Annals of Surgery. 258: 262-9. PMID 23222033 DOI: 10.1097/SLA.0b013e31827a0e82  0.01
2013 Quinney SK, Malireddy SR, Vuppalanchi R, Hamman MA, Chalasani N, Gorski JC, Hall SD. Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin. European Journal of Clinical Pharmacology. 69: 439-48. PMID 22777148 DOI: 10.1007/s00228-012-1339-x  0.01
2012 Duke JD, Han X, Wang Z, Subhadarshini A, Karnik SD, Li X, Hall SD, Jin Y, Callaghan JT, Overhage MJ, Flockhart DA, Strother RM, Quinney SK, Li L. Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions. Plos Computational Biology. 8: e1002614. PMID 22912565 DOI: 10.1371/journal.pcbi.1002614  0.01
2012 Yu P, Dean RA, Hall SD, Qi Y, Sethuraman G, Willis BA, Siemers ER, Martenyi F, Tauscher JT, Schwarz AJ. Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia. Journal of Alzheimer's Disease : Jad. 32: 373-85. PMID 22796873 DOI: 10.3233/JAD-2012-120832  0.01
2012 Ayan-Oshodi MA, Willis BA, Annes WF, Lowe SL, Friedrich S, de la Peña A, Zhang W, Brown T, Wise SD, Hall SD. The effects on metabolic clearance when administering a potent CYP3A autoinducer with the prototypic CYP3A inhibitor, ketoconazole. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 40: 1945-52. PMID 22789530 DOI: 10.1124/dmd.112.046060  0.01
2012 Thirumaran RK, Lamba JK, Kim RB, Urquhart BL, Gregor JC, Chande N, Fan Y, Qi A, Cheng C, Thummel KE, Hall SD, Schuetz EG. Intestinal CYP3A4 and midazolam disposition in vivo associate with VDR polymorphisms and show seasonal variation. Biochemical Pharmacology. 84: 104-12. PMID 22484315 DOI: 10.1016/j.bcp.2012.03.017  0.01
2012 Zhang W, Ayan-Oshodi M, Willis BA, Annes W, Hall SD, Chiesa J, Seger M. QT effect of semagacestat at therapeutic and supratherapeutic doses International Journal of Clinical Pharmacology and Therapeutics. 50: 290-299. PMID 22456300 DOI: 10.5414/CP201672  0.01
2012 Mao J, Mohutsky MA, Harrelson JP, Wrighton SA, Hall SD. Predictions of cytochrome P450-mediated drug-drug interactions using cryopreserved human hepatocytes: comparison of plasma and protein-free media incubation conditions. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 40: 706-16. PMID 22228749 DOI: 10.1124/dmd.111.043158  0.01
2011 Egbelakin A, Ferguson MJ, MacGill EA, Lehmann AS, Topletz AR, Quinney SK, Li L, McCammack KC, Hall SD, Renbarger JL. Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia. Pediatric Blood & Cancer. 56: 361-7. PMID 21225912 DOI: 10.1002/pbc.22845  0.01
2011 Mao J, Mohutsky MA, Harrelson JP, Wrighton SA, Hall SD. Prediction of CYP3A-mediated drug-drug interactions using human hepatocytes suspended in human plasma. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 39: 591-602. PMID 21212240 DOI: 10.1124/dmd.110.036400  0.01
2011 Vuppalanchi R, Juluri R, Ghabril M, Kim S, Thong N, Gorski JC, Chalasani N, Hall SD. Drug-induced QT prolongation in cirrhotic patients with transjugular intrahepatic portosystemic shunt. Journal of Clinical Gastroenterology. 45: 638-42. PMID 20962670 DOI: 10.1097/MCG.0b013e3181f8c522  0.01
2010 Cramer YS, Rosenkranz SL, Hall SD, Szczech LA, Amorosa V, Gupta SK. Hemodialysis does not significantly affect the pharmacokinetics of nevirapine in HIV-1-infected persons requiring hemodialysis: results from ACTG A5177. Journal of Acquired Immune Deficiency Syndromes (1999). 54: e7-9. PMID 20611034 DOI: 10.1097/QAI.0b013e3181e2d5e5  0.01
2010 Chiorean EG, Malireddy S, Younger AE, Jones DR, Waddell MJ, Sloop MI, Yu M, Hall SD, Schneider B, Sweeney CJ. A phase I dose escalation and pharmacokinetic study of vatalanib (PTK787/ZK 222584) in combination with paclitaxel in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 66: 441-8. PMID 20091169 DOI: 10.1007/s00280-009-1179-2  0.01
2010 Quinney SK, Zhang X, Lucksiri A, Gorski JC, Li L, Hall SD. Physiologically based pharmacokinetic model of mechanism-based inhibition of CYP3A by clarithromycin. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 38: 241-8. PMID 19884323 DOI: 10.1124/dmd.109.028746  0.01
2010 Zhang X, Galinsky RE, Kimura RE, Quinney SK, Jones DR, Hall SD. Inhibition of CYP3A by erythromycin: in vitro-in vivo correlation in rats. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 38: 61-72. PMID 19797607 DOI: 10.1124/dmd.109.028290  0.01
2009 Kim S, Hall SD, Li L. A novel Gibbs maximum a posteriori (GMAP) approach on Bayesian nonlinear mixed-effects population pharmacokinetics (PK) models. Journal of Biopharmaceutical Statistics. 19: 700-20. PMID 20183435 DOI: 10.1080/10543400902964159  0.01
2009 Zhou J, Qin Z, Sara QK, Kim S, Wang Z, Hall SD, Li L. Drug-drug interaction prediction assessment. Journal of Biopharmaceutical Statistics. 19: 641-57. PMID 20183431 DOI: 10.1080/10543400902964084  0.01
2009 Zhang X, Quinney SK, Gorski JC, Jones DR, Hall SD. Semiphysiologically based pharmacokinetic models for the inhibition of midazolam clearance by diltiazem and its major metabolite. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 37: 1587-97. PMID 19420129 DOI: 10.1124/dmd.109.026658  0.01
2009 Wang Z, Kim S, Quinney SK, Guo Y, Hall SD, Rocha LM, Li L. Literature mining on pharmacokinetics numerical data: a feasibility study. Journal of Biomedical Informatics. 42: 726-35. PMID 19345282 DOI: 10.1016/j.jbi.2009.03.010  0.01
2009 Zhou J, Qin Z, Quinney SK, Kim S, Wang Z, Yu M, Chien JY, Lucksiri A, Hall SD, Li L. A new probabilistic rule for drug-dug interaction prediction. Journal of Pharmacokinetics and Pharmacodynamics. 36: 1-18. PMID 19156505 DOI: 10.1007/s10928-008-9107-3  0.01
2009 Zhang X, Jones DR, Hall SD. Prediction of the effect of erythromycin, diltiazem, and their metabolites, alone and in combination, on CYP3A4 inhibition. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 37: 150-60. PMID 18854379 DOI: 10.1124/dmd.108.022178  0.01
2008 Wang MZ, Wu JQ, Dennison JB, Bridges AS, Hall SD, Kornbluth S, Tidwell RR, Smith PC, Voyksner RD, Paine MF, Hall JE. A gel-free MS-based quantitative proteomic approach accurately measures cytochrome P450 protein concentrations in human liver microsomes. Proteomics. 8: 4186-96. PMID 18792928 DOI: 10.1002/pmic.200800144  0.01
2008 Gupta SK, Rosenkranz SL, Cramer YS, Koletar SL, Szczech LA, Amorosa V, Hall SD. The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis. Aids (London, England). 22: 1919-27. PMID 18784455 DOI: 10.1097/QAD.0b013e32830e011f  0.01
2008 Dennison JB, Mohutsky MA, Barbuch RJ, Wrighton SA, Hall SD. Apparent high CYP3A5 expression is required for significant metabolism of vincristine by human cryopreserved hepatocytes. The Journal of Pharmacology and Experimental Therapeutics. 327: 248-57. PMID 18650247 DOI: 10.1124/jpet.108.139998  0.01
2008 Dennison JB, Renbarger JL, Walterhouse DO, Jones DR, Hall SD. Quantification of vincristine and its major metabolite in human plasma by high-performance liquid chromatography/tandem mass spectrometry. Therapeutic Drug Monitoring. 30: 357-64. PMID 18520608 DOI: 10.1097/FTD.0b013e31816b92c9  0.01
2008 Quinney SK, Galinsky RE, Jiyamapa-Serna VA, Chen Y, Hamman MA, Hall SD, Kimura RE. Hydroxyitraconazole, formed during intestinal first-pass metabolism of itraconazole, controls the time course of hepatic CYP3A inhibition and the bioavailability of itraconazole in rats. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 1097-101. PMID 18339815 DOI: 10.1124/dmd.108.020644  0.01
2008 Renbarger JL, McCammack KC, Rouse CE, Hall SD. Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients. Pediatric Blood & Cancer. 50: 769-71. PMID 18085684 DOI: 10.1002/pbc.21435  0.01
2008 Quinney SK, Haehner BD, Rhoades MB, Lin Z, Gorski JC, Hall SD. Interaction between midazolam and clarithromycin in the elderly. British Journal of Clinical Pharmacology. 65: 98-109. PMID 17635500 DOI: 10.1111/j.1365-2125.2007.02970.x  0.01
2007 Jones DR, Ekins S, Li L, Hall SD. Computational approaches that predict metabolic intermediate complex formation with CYP3A4 (+b5). Drug Metabolism and Disposition: the Biological Fate of Chemicals. 35: 1466-75. PMID 17537872 DOI: 10.1124/dmd.106.014613  0.01
2007 Kolwankar D, Vuppalanchi R, Ethell B, Jones DR, Wrighton SA, Hall SD, Chalasani N. Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 5: 388-93. PMID 17368239 DOI: 10.1016/j.cgh.2006.12.021  0.01
2007 Li L, Yu M, Chin R, Lucksiri A, Flockhart DA, Hall SD. Drug-drug interaction prediction: a Bayesian meta-analysis approach. Statistics in Medicine. 26: 3700-21. PMID 17357990 DOI: 10.1002/sim.2837  0.01
2007 Dennison JB, Jones DR, Renbarger JL, Hall SD. Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes. The Journal of Pharmacology and Experimental Therapeutics. 321: 553-63. PMID 17272675 DOI: 10.1124/jpet.106.118471  0.01
2006 Dennison JB, Kulanthaivel P, Barbuch RJ, Renbarger JL, Ehlhardt WJ, Hall SD. Selective metabolism of vincristine in vitro by CYP3A5. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 34: 1317-27. PMID 16679390 DOI: 10.1124/dmd.106.009902  0.01
2006 Huang R, Murry DJ, Kolwankar D, Hall SD, Foster DR. Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell lines. Biochemical Pharmacology. 71: 1695-704. PMID 16620787 DOI: 10.1016/j.bcp.2006.03.009  0.01
2006 Chien JY, Lucksiri A, Ernest CS, Gorski JC, Wrighton SA, Hall SD. Stochastic prediction of CYP3A-mediated inhibition of midazolam clearance by ketoconazole. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 34: 1208-19. PMID 16611859 DOI: 10.1124/dmd.105.008730  0.01
2006 Lemma GL, Wang Z, Hamman MA, Zaheer NA, Gorski JC, Hall SD. The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates. Clinical Pharmacology and Therapeutics. 79: 218-30. PMID 16513446 DOI: 10.1016/j.clpt.2005.11.001  0.01
2005 Chalasani N, Teal E, Hall SD. Effect of rosiglitazone on serum liver biochemistries in diabetic patients with normal and elevated baseline liver enzymes. The American Journal of Gastroenterology. 100: 1317-21. PMID 15929763 DOI: 10.1111/j.1572-0241.2005.41690.x  0.01
2005 Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA, Tashima KT, Roland M, Franceschini N, Palella FJ, Lennox JL, Klotman PE, Nachman SA, Hall SD, Szczech LA. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 40: 1559-85. PMID 15889353 DOI: 10.1086/430257  0.01
2005 Liangpunsakul S, Kolwankar D, Pinto A, Gorski JC, Hall SD, Chalasani N. Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholics. Hepatology (Baltimore, Md.). 41: 1144-50. PMID 15841467 DOI: 10.1002/hep.20673  0.01
2005 Borges S, Li L, Hamman MA, Jones DR, Hall SD, Gorski JC. Dextromethorphan to dextrorphan urinary metabolic ratio does not reflect dextromethorphan oral clearance. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 33: 1052-5. PMID 15821042 DOI: 10.1124/dmd.104.003459  0.01
2005 Pinto AG, Wang YH, Chalasani N, Skaar T, Kolwankar D, Gorski JC, Liangpunsakul S, Hamman MA, Arefayene M, Hall SD. Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expression. Clinical Pharmacology and Therapeutics. 77: 178-88. PMID 15735612 DOI: 10.1016/j.clpt.2004.10.002  0.01
2005 Adigun AQ, Pinto AG, Flockhart DA, Gorski JC, Li L, Hall SD, Chalasani N. Effect of cirrhosis and liver transplantation on the gender difference in QT interval. The American Journal of Cardiology. 95: 691-4. PMID 15721125 DOI: 10.1016/j.amjcard.2004.10.054  0.01
2005 Wang YH, Jones DR, Hall SD. Differential mechanism-based inhibition of CYP3A4 and CYP3A5 by verapamil. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 33: 664-71. PMID 15689501 DOI: 10.1124/dmd.104.001834  0.01
2005 Ho H, Pinto A, Hall SD, Flockhart DA, Li L, Skaar TC, Cadman P, O'Connor DT, Wagner U, Fineberg NS, Weinberger MH. Association between the CYP3A5 genotype and blood pressure. Hypertension (Dallas, Tex. : 1979). 45: 294-8. PMID 15596575 DOI: 10.1161/01.HYP.0000151361.31736.96  0.01
2005 Ernest CS, Hall SD, Jones DR. Mechanism-based inactivation of CYP3A by HIV protease inhibitors. The Journal of Pharmacology and Experimental Therapeutics. 312: 583-91. PMID 15523003 DOI: 10.1124/jpet.104.075416  0.01
2005 Hall SD, Barnes GR, Hillebrand A, Furlong PL, Singh KD, Holliday IE. Cortical Spreading Depression Is Neuroprotective: The Challenge of Basic Sciences-A Response Headache: the Journal of Head and Face Pain. 45: 178-178. DOI: 10.1111/j.1526-4610.2005.05039_2.x  0.01
2004 Uhing MR, Beno DW, Jiyamapa-Serna VA, Chen Y, Galinsky RE, Hall SD, Kimura RE. The effect of anesthesia and surgery on CYP3A activity in rats. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 32: 1325-30. PMID 15319324 DOI: 10.1124/dmd.104.000927  0.01
2004 Chalasani N, Aljadhey H, Kesterson J, Murray MD, Hall SD. Patients with Elevated Liver Enzymes Are Not at Higher Risk for Statin Hepatotoxicity Gastroenterology. 126: 1287-1292. PMID 15131789 DOI: 10.1053/j.gastro.2004.02.015  0.01
2004 Gorski JC, Huang SM, Pinto A, Hamman MA, Hilligoss JK, Zaheer NA, Desai M, Miller M, Hall SD. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo Clinical Pharmacology and Therapeutics. 75: 89-100. PMID 14749695 DOI: 10.1016/j.clpt.2003.09.013  0.01
2004 Huang SM, Hall SD, Watkins P, Love LA, Serabjit-Singh C, Betz JM, Hoffman FA, Honig P, Coates PM, Bull J, Chen ST, Kearns GL, Murray MD. Drug interactions with herbal products and grapefruit juice: a conference report. Clinical Pharmacology and Therapeutics. 75: 1-12. PMID 14749688 DOI: 10.1016/j.clpt.2003.07.002  0.01
2004 Wang YH, Jones DR, Hall SD. Prediction of cytochrome P450 3A inhibition by verapamil enantiomers and their metabolites Drug Metabolism and Disposition. 32: 259-266. PMID 14744949 DOI: 10.1124/dmd.32.2.259  0.01
2003 Hall SD, Wang Z, Huang SM, Hamman MA, Vasavada N, Adigun AQ, Hilligoss JK, Miller M, Gorski JC. The interaction between St John's wort and an oral contraceptive Clinical Pharmacology and Therapeutics. 74: 525-535. PMID 14663455 DOI: 10.1016/j.clpt.2003.08.009  0.01
2003 Gorski JC, Vannaprasaht S, Hamman MA, Ambrosius WT, Bruce MA, Haehner-Daniels B, Hall SD. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity Clinical Pharmacology and Therapeutics. 74: 275-287. PMID 12966371 DOI: 10.1016/S0009-9236(03)00187-5  0.01
2003 Ward BA, Gorski JC, Jones DR, Hall SD, Flockhart DA, Desta Z. The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: Implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity Journal of Pharmacology and Experimental Therapeutics. 306: 287-300. PMID 12676886 DOI: 10.1124/jpet.103.049601  0.01
2003 Chalasani N, Christopher Gorski J, Asghar MS, Asghar A, Foresman B, Hall SD, Crabb DW. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis Hepatology. 37: 544-550. PMID 12601351 DOI: 10.1053/jhep.2003.50095  0.01
2003 Wang Z, Hall SD, Maya JF, Li L, Asghar A, Gorski JC. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans British Journal of Clinical Pharmacology. 55: 77-85. PMID 12534643 DOI: 10.1046/j.1365-2125.2003.01731.x  0.01
2002 Andrew Williams J, Ring BJ, Cantrell VE, Campanale K, Jones DR, Hall SD, Wrighton SA. Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes Drug Metabolism and Disposition. 30: 1266-1273. PMID 12386134 DOI: 10.1124/dmd.30.11.1266  0.01
2002 Andrew Williams J, Ring BJ, Cantrell VE, Jones DR, Eckstein J, Ruterbories K, Hamman MA, Hall SD, Wrighton SA. Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7 Drug Metabolism and Disposition. 30: 883-891. PMID 12124305 DOI: 10.1124/dmd.30.8.883  0.01
2002 Wang Z, Hamman MA, Huang SM, Lesko LJ, Hall SD. Effect of St John's wort on the pharmacokenetics of fexofenadine Clinical Pharmacology and Therapeutics. 71: 414-420. PMID 12087344 DOI: 10.1067/mcp.2002.124080  0.01
2002 Belle DJ, Callaghan JT, Gorski JC, Maya JF, Mousa O, Wrighton SA, Hall SD. The effects of an oral contraceptive containing ethinyloestradiol and norgestrel on CYP3A activity. British Journal of Clinical Pharmacology. 53: 67-74. PMID 11849197 DOI: 10.1046/j.0306-5251.2001.01521.x  0.01
2002 Shaw AA, Hall SD, Franklin MR, Galinsky RE. The influence of L-glutamine on the depression of hepatic cytochrome P450 activity in male rats caused by total parenteral nutrition Drug Metabolism and Disposition. 30: 177-182. PMID 11792688 DOI: 10.1124/dmd.30.2.177  0.01
2002 Asghar A, Gorski JC, Haehner-Daniels B, Hall SD. Induction of multidrug resistance-1 and cytochrome P450 mRNAS in human mononuclear cells by rifampin Drug Metabolism and Disposition. 30: 20-26. PMID 11744607 DOI: 10.1124/dmd.30.1.20  0.01
Hide low-probability matches.